EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,786,000 | -24.4% | 57,525 | 0.0% | 0.05% | -12.1% |
| Q1 2022 | $2,362,000 | -5.6% | 57,525 | 0.0% | 0.06% | 0.0% |
| Q4 2021 | $2,501,000 | -13.2% | 57,525 | 0.0% | 0.06% | -17.1% |
| Q3 2021 | $2,880,000 | -18.3% | 57,525 | +2.9% | 0.07% | -13.6% |
| Q2 2021 | $3,523,000 | -32.2% | 55,925 | 0.0% | 0.08% | -34.7% |
| Q1 2021 | $5,196,000 | -1.1% | 55,925 | -4.6% | 0.12% | -4.6% |
| Q4 2020 | $5,253,000 | -19.5% | 58,625 | -7.1% | 0.13% | -27.4% |
| Q3 2020 | $6,523,000 | +18.5% | 63,125 | -9.3% | 0.18% | +27.0% |
| Q2 2020 | $5,506,000 | +35.3% | 69,625 | -1.0% | 0.14% | +17.5% |
| Q1 2020 | $4,069,000 | +4.7% | 70,325 | -2.4% | 0.12% | +48.1% |
| Q4 2019 | $3,887,000 | -45.5% | 72,045 | -47.2% | 0.08% | -43.8% |
| Q3 2019 | $7,128,000 | +22.8% | 136,344 | +13.5% | 0.14% | +30.9% |
| Q2 2019 | $5,803,000 | -0.5% | 120,110 | +4.1% | 0.11% | +0.9% |
| Q1 2019 | $5,832,000 | – | 115,434 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIMZ Investment Advisors, LLC | 52,590 | $621 | 0.29% |
| Values First Advisors, Inc. | 33,942 | $400,858 | 0.28% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 91,000 | $1,075,000 | 0.23% |
| SummerHaven Investment Management, LLC | 25,347 | $299,348 | 0.18% |
| PALISADE CAPITAL MANAGEMENT, LP | 501,672 | $5,924,746 | 0.16% |
| CORNERCAP INVESTMENT COUNSEL INC | 67,457 | $796,667 | 0.14% |
| Edgestream Partners, L.P. | 94,553 | $1,116,671 | 0.13% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 86,569 | $1,022,380 | 0.12% |
| DUALITY ADVISERS, LP | 77,298 | $912,889 | 0.10% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,253,042 | $14,798,427 | 0.10% |